In Second Letter, Roche Urges Illumina Shareholders to Accept 'Highly Attractive' Offer | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) — In its pursuit to acquire Illumina in a hostile takeover, Roche has again turned directly to the company's shareholders, aiming to convince them of the attractiveness of its offer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: peanut subgenome progenitor sequence, homozygosity mapping and linkage analyses using exome data, and more.

Tech companies like Microsoft are looking into DNA as a data storage device, Scientific American writes.

The New York Times writes that the Max Planck Institute for Infection Biology's Emmanuelle Charpentier has always been on the move, though now it's more about CRISPR.

The European Union calls for all publicly funded scientific papers to be immediately freely accessible to the public by 2020.